Should fluoroquinolones be first-line antibiotics in the treatment of community-acquired pneumonia in areas with high incidence of tuberculosis?
Hsueh
Po Ren
PR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy; D024841:Fluoroquinolones / Q000627:therapeutic use*; D006801:Humans; D011014:Pneumonia / Q000188:drug therapy*; D013624:Taiwan / Q000453:epidemiology; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology*
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones